• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Protocadherin Fat 4 (FAT4), Truncated

ACP16538

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16538 Target NameFAT4
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6V0I7
Background Information
  • Uniprot Id

    Q6V0I7

  • Target Species

    Human

  • Target Name

    FAT4

  • Target Full Name

    Protocadherin Fat 4

  • Target Function

    Cadherins are calcium-dependent cell adhesion proteins. FAT4 plays a role in the maintenance of planar cell polarity as well as in inhibition of YAP1-mediated neuroprogenitor cell proliferation and differentiation.

  • Target Involvement

    Van Maldergem syndrome 2 (VMLDS2); Hennekam lymphangiectasia-lymphedema syndrome 2 (HKLLS2)

  • Target Subcellular Location

    Membrane; Single-pass type I membrane protein.

  • Target Tissue Specificity

    Widely expressed. Expressed in fetal brain, infant brain, brain tumor and colorectal cancer.

  • Target Synonyms

    Cadherin family member 14; Cadherin related family member 11; CDHF14; CDHR11; FAT atypical cadherin 4; FAT J; FAT tumor suppressor homolog 4; Fat-like cadherin protein FAT-J; FAT4; FAT4_HUMAN; FATJ; hFat4; HKLLS2; Nbla00548; Protocadherin Fat 4; Putative protein product of Nbla00548; VMLDS2

Inquire Recombinant Human Protocadherin Fat 4 (FAT4), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification